Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0168
+0.0090 (115.38%)
Last updated: Apr 24, 2026, 9:32 AM CET
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €2.26 million as of April 24, 2026. Its market cap has decreased by -96.25% in one year.
Market Cap
2.26M
Enterprise Value
21.57M
Revenue
55.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.02
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 2.26M, a decrease of -99.79%. That is a compound annual growth rate of -43.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 3.39M | -42.20% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 50.84M |
| Biomark Diagnostics | 35.52M |
| Paion AG | 545.73K |
| co.don AG | 347.40K |
| bioXXmed AG | 301.77K |
| MagForce AG | 122.29K |